共 41 条
- [2] Anastas P.T., 1998, Frontiers
- [3] [Anonymous], 2022, FDA approves olaparib for adjuvant treatment of high-risk early breast cancer
- [4] [Anonymous], 2018, FDA approves olaparib germline BRCA- mutated metastatic breast cancer
- [5] Bell AS, 1992, European Patent Application, Patent No. [0463756A1, 0463756]
- [6] BRASIL. Ministerio da Saude. Agencia Nacional de Vigilancia Sanitaria, 2016, RESOLUCAO DA DIRETORIA COLEGIADA-RDC N 73, DE 7 DE ABRIL DE 2016